Log in
Enquire now
‌

US Patent 11591329 Bicyclic heterocycles as FGFR inhibitors

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Incyte
Incyte
Current Assignee
Incyte
Incyte
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11591329
Date of Patent
February 28, 2023
Patent Application Number
16923799
Date Filed
July 8, 2020
Patent Citations
‌
US Patent 10214528 Bicyclic heterocycles as FGFR4 inhibitors
‌
US Patent 10251892 Bicyclic heterocycles as FGFR4 inhibitors
‌
US Patent 10308644 Heterocyclic compounds as immunomodulators
‌
US Patent 10350240 Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
‌
US Patent 10357431 Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient
‌
US Patent 10450313 Bicyclic heterocycles as FGFR inhibitors
‌
US Patent 10611762 Crystalline forms of a FGFR inhibitor and processes for preparing the same
‌
US Patent 10632126 Bicyclic heterocycles as FGFR4 inhibitors
...
Patent Primary Examiner
‌
Niloofar Rahmani
CPC Code
‌
C07D 471/04
‌
C07D 519/00
No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11591329 Bicyclic heterocycles as FGFR inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.